Multidrug-resistant tuberculosis management in three French hospitals

Médecine et maladies infectieuses
S GreffeS Abgrall

Abstract

Multidrug-resistant tuberculosis (MDR-TB) management is based on specific WHO guidelines. The authors report MDR-TB management, in three French hospitals. The authors retrospectively included patients with positive sample for multidrug-resistant Mycobacterium tuberculosis (isoniazid+rifampicin) from January 1, 2000 to December 31, 2005. The management was compared to the French and international prevalent guidelines. Sixteen patients were initially managed for MDR-TB by eight different medical teams over 6 successive years: 12 (75%) presented with primary MDR-TB. Management advice from the national referee center (NRC) for tuberculosis was reported in seven out of 14 treated cases. The median length of the intensive treatment was 2 months (IQR: 1-3). Eight patients (58%) had an overall treatment length of 18 months. The median number of effective drugs prescribed was 4 (IQR: 4-5). Nine patients (64%) were also managed in a sanatorium. Only eight patients (57%) completed the prescribed treatment. Nine patients were clinically cured and still followed-up, six of whom were bacteriologically cured. TB-MDR management was not conform to WHO guidelines in our study. Management in a sanatorium, NRC involvement, ambulatory DOT were high...Continue Reading

References

Jul 27, 1995·The New England Journal of Medicine·T R FriedenM A Hamburg
Feb 25, 1993·The New England Journal of Medicine·M GobleC R Horsburgh
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·M Flament-SaillourJ Grosset
Jul 21, 2001·The New England Journal of Medicine·K TahaoğluN Kapakli
Feb 16, 2007·International Journal of Antimicrobial Agents·Marie-Laure UffrediJérôme Robert
Aug 11, 2011·The European Respiratory Journal·D FalzonM Zignol

❮ Previous
Next ❯

Citations

Jul 27, 2015·Revue de pneumologie clinique·S Smaoui FouratiF Messadi-Akrout

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.